Blood Cancer

July 07, 2021

New research and updated treatment guidelines add to knowledge base on this rare blood cancer.

July 06, 2021

The Leukemia & Lymphoma Society is providing grants to increase trial enrollment of ethnic and racial minorities.

June 07, 2021

Researchers are making progress in identifying drugs that target certain mutations.

June 06, 2021

Phase 1b results show manageable toxicities with Venclexta and Rydapt.

June 02, 2021

NCCN recommends Brukinsa for CLL/SLL even though it is FDA-approved for mantel cell lymphoma.

January 20, 2021

Deposing the ‘Emperor of All Maladies’ will take a diverse toolkit, not a single moonshot.

November 23, 2020

In the early going, patients seeking the expensive, customized cancer treatments called CAR-T cell therapy had to go to an academic medical center. But that’s changing, as Duncan Allen, M.H.A., of the community cancer network OneOncology explains.

August 02, 2020

In a busy week, FDA approved ground-breaking therapies in hematologic cancers and issued Orphan Drug designations in areas of significant unmet need.

June 28, 2020

An off-the-shelf version of CAR-T therapy that uses the immune system’s natural killer cells is a possibility. But the high price of CAR-T shows some doubts about how widely it can be used.

November 10, 2019

Cancer care enters a new, exciting phase, experts say.